| Literature DB >> 16895698 |
Aude Servais1, Philippe Lechat, Noël Zahr, Saik Urien, Guy Aymard, Marie Chantal Jaudon, Gilbert Deray, Corinne Isnard Bagnis.
Abstract
Adefovir is transported by the organic anion transporter (OAT1) and the multidrug resistant protein (MRP2, 4 and 5). We studied adefovir clearance in rat after inhibition of transporters by probenecid and in TR- rats, in which MRP2 is lacking. After treatment by probenecid or placebo, pharmacokinetics of adefovir 10 mg/kg was studied via population modeling (NONMEM). The fraction of drug excreted in the urine was low. Renal clearance of adefovir was significantly lower (P < 0.05) in probenecid TR- rats (0.03 +/- 0.02 l/hour) than in normal control (0.09 +/- 0.05 l/hour), in normal probenecid (0.10 +/- 0.07 l/hour) and in TR- control rats (0.13 +/- 0.07 l/hour). In vivo in rats MRP2 mutation alone did not affect adefovir clearance suggesting that MRP2 does not play a critical role in the secretion of adefovir. Additional pharmacological inhibition of transporters decreased renal clearance, which may reflect inhibition of compensating transport mechanisms activated when MRP2 is lacking.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16895698 DOI: 10.1016/j.nephro.2005.06.011
Source DB: PubMed Journal: Nephrol Ther ISSN: 1769-7255 Impact factor: 0.722